Mutations and thrombosis in essential thrombocythemia

Tefferi, A. & Barbui, T. Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management. Am. J. Hematol. 95 , 1599–1613 (2020). Article CAS Google Scholar Szuber, N. et al. Myeloproliferative neoplasms in the young: Mayo Clinic experience with 361 patients age 40 years or younger. Am. J. Hematol. 93 , 1474–1484 (2018). Article CAS Google Scholar Tefferi, A. et al. Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera. Br. J. Haematol. 189 , 291–302 (2020). Article CAS Google Scholar Arber, D. A. et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127 , 2391–2405 (2016). Article CAS Google Scholar Tefferi, A. et al. Targeted deep sequencing in polycythemia vera and essential thrombocythemia. Blood Adv. 1 , 21–30 (2016). Article CAS Google Scholar Lasho, T. L., Finke, C. M., Tischer, A., Pardanani, A. & Tefferi, A. Mayo CALR mutation type classification guide using alpha helix propensity. Am. J. Hematol. 93 , E128–E129 (2018). Article Google Scholar Carobbio, A. et al. Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients. Blood 117 , 5857–5859 (2011). Article CAS Google Scholar Tefferi, A. et al. Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: a collaborative study of 1027 patients. Am. J. Hematol. 89 , E121–E124 (2014). Article CAS Google Scholar Barbui, T. et al. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study. J. Clin. Oncol. 29 , 3179–3184 (2011). Article Google Scholar Gangat, N. et al. Young platelet millionaires with essential thrombocythemia. Am. J. Hematol. https://doi.org/10.1002/ajh.26114 (2021). Finazzi, G. et al. Calreticulin mutation does not modify the IPSET score for predicting the risk of thrombosis among 1150 patients with essential thrombocythemia. Blood 124 , 2611–2612 (2014). Article CAS Google Scholar Gangat, N. et al. Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history. Eur. J. Haematol. 94 , 31–36 (2015). Article CAS Google Scholar Barbui, T. Refining prognostication of thrombosis in ET. Am. J. Hematol. 91 , 361–363 (2016). Article Google Scholar Michiels, J. J. et al. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera. Semin. Thromb. Hemost. 32 , 589–604 (2006). Article CAS Google Scholar Download references